About this trial
The objective of the study is to establish a registry of patients diagnosed with Chronic Rhinosinusitis with and without Nasal Polyps (CRSwNP/CRSsNP) to collect comprehensive longitudinal real-world evidence from specialised treatment centres in Germany. The primary analysis will concentrate on the treatment efficacy and safety of biologic drugs with a focus on defining disease Control, Remission, and Cure as well as to validate the corresponding clinical evaluation criteria.
Eligibility criteria
Qualifiers
Patients above the age of 12 years
Patients who are diagnosed with CRS according to internationally valid guidelines (EPOS 2020)
Patients who provide written informed consent or by a legal representative
Disqualifiers
Patients below the age of 12 years at initiation
Patients who do not provide written consent or withdraw their consent
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
Sponsors and collaborators
Ärzteverband Deutscher Allergologen e.V.
Lead sponsor
German Society of Otorhinolaryngology, Head and Neck Surgery
Collaborator